These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 26271952)

  • 1. The Endocannabinoid System and its Modulation by Phytocannabinoids.
    Di Marzo V; Piscitelli F
    Neurotherapeutics; 2015 Oct; 12(4):692-8. PubMed ID: 26271952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabimimetic plants: are they new cannabinoidergic modulators?
    Kumar A; Premoli M; Aria F; Bonini SA; Maccarinelli G; Gianoncelli A; Memo M; Mastinu A
    Planta; 2019 Jun; 249(6):1681-1694. PubMed ID: 30877436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.
    Cabral GA; Rogers TJ; Lichtman AH
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):193-203. PubMed ID: 26054900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system and pain.
    Guindon J; Hohmann AG
    CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.
    Reggio PH
    Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRP Channels as Novel Targets for Endogenous Ligands: Focus on Endocannabinoids and Nociceptive Signalling.
    Storozhuk MV; Zholos AV
    Curr Neuropharmacol; 2018 Jan; 16(2):137-150. PubMed ID: 28440188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of the endocannabinoid system in the sleep-wake cycle modulation.
    Murillo-Rodriguez E; Poot-Ake A; Arias-Carrion O; Pacheco-Pantoja E; Fuente-Ortegon Ade L; Arankowsky-Sandoval G
    Cent Nerv Syst Agents Med Chem; 2011 Sep; 11(3):189-96. PubMed ID: 21919868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid chemical biology: a tool for the development of novel therapies.
    Petrosino S; Ligresti A; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):309-20. PubMed ID: 19457702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
    Basavarajappa BS; Nixon RA; Arancio O
    Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels.
    De Petrocellis L; Di Marzo V
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):103-21. PubMed ID: 19847654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocannabinoids as Therapeutic Targets.
    Prospéro-García O; Ruiz Contreras AE; Ortega Gómez A; Herrera-Solís A; Méndez-Díaz M;
    Arch Med Res; 2019 Nov; 50(8):518-526. PubMed ID: 32028095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid system in neurodegenerative disorders.
    Basavarajappa BS; Shivakumar M; Joshi V; Subbanna S
    J Neurochem; 2017 Sep; 142(5):624-648. PubMed ID: 28608560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
    Gertsch J
    Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
    Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
    CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid mechanisms of pain modulation.
    Hohmann AG; Suplita RL
    AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Saario S; Nevalainen T
    Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.
    Giuffrida A; McMahon LR
    Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):90-103. PubMed ID: 19523530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of Multiverse Activities of Endocannabinoids in Biological Systems.
    Behl T; Makkar R; Sehgal A; Singh S; Makeen HA; Albratty M; Alhazmi HA; Meraya AM; Bungau S
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.